Carol Pamer

744 total citations
15 papers, 541 citations indexed

About

Carol Pamer is a scholar working on Psychiatry and Mental health, Toxicology and Molecular Biology. According to data from OpenAlex, Carol Pamer has authored 15 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Toxicology and 3 papers in Molecular Biology. Recurrent topics in Carol Pamer's work include Pharmacovigilance and Adverse Drug Reactions (4 papers), Child Nutrition and Feeding Issues (2 papers) and Biomedical Text Mining and Ontologies (2 papers). Carol Pamer is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (4 papers), Child Nutrition and Feeding Issues (2 papers) and Biomedical Text Mining and Ontologies (2 papers). Carol Pamer collaborates with scholars based in United States, Sweden and Russia. Carol Pamer's co-authors include Allen Brinker, Jerry L. Phillips, Peter K. Honig, Ann Corken Mackey, Marian I. Butterfield, Douglas Shaffer, Andrew D. Mosholder, Robert Ball, Nabarun Dasgupta and Harold Rodriguez and has published in prestigious journals such as Journal of the American Medical Informatics Association, Drug Safety and Journal of Biomedical Informatics.

In The Last Decade

Carol Pamer

14 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Pamer United States 8 193 184 124 78 50 15 541
Katherine Simons Netherlands 4 212 1.1× 244 1.3× 146 1.2× 111 1.4× 80 1.6× 6 517
Joanna E. Klopotowska Netherlands 13 249 1.3× 305 1.7× 96 0.8× 74 0.9× 40 0.8× 31 542
A.D. Small United Kingdom 5 275 1.4× 301 1.6× 149 1.2× 98 1.3× 106 2.1× 9 794
Sarah McDowell United Kingdom 14 190 1.0× 213 1.2× 71 0.6× 76 1.0× 100 2.0× 34 835
Penkarn Kanjanarat Thailand 9 182 0.9× 231 1.3× 113 0.9× 94 1.2× 45 0.9× 16 450
Peter C. Wierenga Netherlands 13 132 0.7× 230 1.3× 74 0.6× 60 0.8× 138 2.8× 18 522
Mohammadreza Javadi Iran 17 142 0.7× 310 1.7× 64 0.5× 91 1.2× 40 0.8× 43 699
Rianne J. Zaal Netherlands 13 203 1.1× 321 1.7× 73 0.6× 63 0.8× 148 3.0× 20 490
Bobbie Jean Sweitzer United States 11 366 1.9× 266 1.4× 84 0.7× 50 0.6× 100 2.0× 21 782
Pieter Cornu Belgium 13 155 0.8× 301 1.6× 56 0.5× 53 0.7× 127 2.5× 40 554

Countries citing papers authored by Carol Pamer

Since Specialization
Citations

This map shows the geographic impact of Carol Pamer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Pamer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Pamer more than expected).

Fields of papers citing papers by Carol Pamer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Pamer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Pamer. The network helps show where Carol Pamer may publish in the future.

Co-authorship network of co-authors of Carol Pamer

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Pamer. A scholar is included among the top collaborators of Carol Pamer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Pamer. Carol Pamer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sankararaman, Senthilkumar, et al.. (2025). Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase‐1 in Children With Cystic Fibrosis. Pediatric Pulmonology. 60(6). e71156–e71156.
2.
Pamer, Carol, et al.. (2021). 86: Post-transition quarterly phone calls and emails increase contact with young adults with CF and address concerns between clinic visits. Journal of Cystic Fibrosis. 20. S43–S43. 1 indexed citations
3.
Pamer, Carol, et al.. (2018). Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology. Journal of Biomedical Informatics. 83. 73–86. 38 indexed citations
5.
Pierce, Carrie E., Carol Pamer, Harold Rodriguez, et al.. (2017). Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. Drug Safety. 40(4). 317–331. 85 indexed citations
6.
Han, Lichy, et al.. (2017). Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting system. Journal of the American Medical Informatics Association. 24(5). 913–920. 25 indexed citations
8.
Pamer, Carol, Tarek A. Hammad, Sigal Kaplan, et al.. (2010). Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions. Pharmacoepidemiology and Drug Safety. 19(2). 158–174. 30 indexed citations
9.
Pamer, Carol, Tracey Serpi, & Joseph Finkelstein. (2008). Analysis of Maryland poisoning deaths using classification and regression tree (CART) analysis.. PubMed. 550–4. 11 indexed citations
10.
Mosholder, Andrew D. & Carol Pamer. (2006). Postmarketing Surveillance of Suicidal Adverse Events with Pediatric Use of Antidepressants. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 33–36. 12 indexed citations
11.
Shaffer, Douglas, Carol Pamer, Ann Corken Mackey, & Marian I. Butterfield. (2004). Tardive Dyskinesia Risks and Metoclopramide Use Before and After U.S. Market Withdrawal of Cisapride. Journal of the American Pharmacists Association. 44(6). 661–665. 43 indexed citations
12.
LaPointe, Nancy M. Allen, Carol Pamer, & Judith M. Kramer. (2003). New Antiarrhythmic Agents for Atrial Fibrillation and Atrial Flutter: United States Drug Market Response as an Indicator of Acceptance. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(10). 1316–1321. 1 indexed citations
13.
Brinker, Allen, Carol Pamer, & Julie Beitz. (2003). Changes in Ciprofloxacin Utilization as Shown in a Large Pharmacy Claims Database: Effects of Proximity to Criminal Anthrax Exposure in October 2001. Journal of the American Pharmacists Association. 43(3). 375–378. 6 indexed citations
14.
Phillips, Jerry L., et al.. (2001). Retrospective analysis of mortalities associated with medication errors. American Journal of Health-System Pharmacy. 58(19). 1835–1841. 276 indexed citations
15.
Pamer, Carol & Jerry L. Phillips. (2000). Medication Errors Associated with Levothyroxine Products. Hospital Pharmacy. 35(12). 1280–1286. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026